0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lysine Specific Demethylase 1 Inhibitor Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-39S12593
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lysine Specific Demethylase 1 Inhibitor Market Research Report 2022
BUY CHAPTERS

Global Lysine Specific Demethylase 1 Inhibitor Market Research Report 2025

Code: QYRE-Auto-39S12593
Report
March 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lysine Specific Demethylase 1 Inhibitor Market

The global market for Lysine Specific Demethylase 1 Inhibitor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Lysine Specific Demethylase 1 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lysine Specific Demethylase 1 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lysine Specific Demethylase 1 Inhibitor include Oryzon Genomics, 4SC, Salarius Pharmaceuticals, Celgene Corporation, Taiho Pharmaceutical, CSPC ZhongQi Pharmaceutical Technology, Beatica, Rasna Therapeutic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lysine Specific Demethylase 1 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysine Specific Demethylase 1 Inhibitor.
The Lysine Specific Demethylase 1 Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lysine Specific Demethylase 1 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lysine Specific Demethylase 1 Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lysine Specific Demethylase 1 Inhibitor Market Report

Report Metric Details
Report Name Lysine Specific Demethylase 1 Inhibitor Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Oryzon Genomics, 4SC, Salarius Pharmaceuticals, Celgene Corporation, Taiho Pharmaceutical, CSPC ZhongQi Pharmaceutical Technology, Beatica, Rasna Therapeutic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lysine Specific Demethylase 1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lysine Specific Demethylase 1 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Lysine Specific Demethylase 1 Inhibitor Market report?

Ans: The main players in the Lysine Specific Demethylase 1 Inhibitor Market are Oryzon Genomics, 4SC, Salarius Pharmaceuticals, Celgene Corporation, Taiho Pharmaceutical, CSPC ZhongQi Pharmaceutical Technology, Beatica, Rasna Therapeutic

What are the Application segmentation covered in the Lysine Specific Demethylase 1 Inhibitor Market report?

Ans: The Applications covered in the Lysine Specific Demethylase 1 Inhibitor Market report are Breast Cancer, Prostate Cancer, Others

What are the Type segmentation covered in the Lysine Specific Demethylase 1 Inhibitor Market report?

Ans: The Types covered in the Lysine Specific Demethylase 1 Inhibitor Market report are Vaccine, Monoclonal Antibody

Recommended Reports

Epigenetics & Inhibitors

Enzyme & Pathway Targets

Pharmaceutical Ingredients

1 Lysine Specific Demethylase 1 Inhibitor Market Overview
1.1 Product Definition
1.2 Lysine Specific Demethylase 1 Inhibitor by Type
1.2.1 Global Lysine Specific Demethylase 1 Inhibitor Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vaccine
1.2.3 Monoclonal Antibody
1.3 Lysine Specific Demethylase 1 Inhibitor by Application
1.3.1 Global Lysine Specific Demethylase 1 Inhibitor Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Others
1.4 Global Lysine Specific Demethylase 1 Inhibitor Market Size Estimates and Forecasts
1.4.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue 2020-2031
1.4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales 2020-2031
1.4.3 Global Lysine Specific Demethylase 1 Inhibitor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lysine Specific Demethylase 1 Inhibitor Market Competition by Manufacturers
2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lysine Specific Demethylase 1 Inhibitor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lysine Specific Demethylase 1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lysine Specific Demethylase 1 Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lysine Specific Demethylase 1 Inhibitor, Product Type & Application
2.7 Global Key Manufacturers of Lysine Specific Demethylase 1 Inhibitor, Date of Enter into This Industry
2.8 Global Lysine Specific Demethylase 1 Inhibitor Market Competitive Situation and Trends
2.8.1 Global Lysine Specific Demethylase 1 Inhibitor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lysine Specific Demethylase 1 Inhibitor Players Market Share by Revenue
2.8.3 Global Lysine Specific Demethylase 1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lysine Specific Demethylase 1 Inhibitor Market Scenario by Region
3.1 Global Lysine Specific Demethylase 1 Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2020-2031
3.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2020-2025
3.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2026-2031
3.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region: 2020-2031
3.3.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region: 2020-2025
3.3.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region: 2026-2031
3.4 North America Lysine Specific Demethylase 1 Inhibitor Market Facts & Figures by Country
3.4.1 North America Lysine Specific Demethylase 1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2031)
3.4.3 North America Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lysine Specific Demethylase 1 Inhibitor Market Facts & Figures by Country
3.5.1 Europe Lysine Specific Demethylase 1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2031)
3.5.3 Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lysine Specific Demethylase 1 Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific Lysine Specific Demethylase 1 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales by Region (2020-2031)
3.6.3 Asia Pacific Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lysine Specific Demethylase 1 Inhibitor Market Facts & Figures by Country
3.7.1 Latin America Lysine Specific Demethylase 1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2031)
3.7.3 Latin America Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2020-2031)
4.1.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2020-2025)
4.1.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2026-2031)
4.1.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2020-2031)
4.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2020-2031)
4.2.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2020-2025)
4.2.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2026-2031)
4.2.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2020-2031)
4.3 Global Lysine Specific Demethylase 1 Inhibitor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2020-2031)
5.1.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2020-2025)
5.1.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2026-2031)
5.1.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2020-2031)
5.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2020-2031)
5.2.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2020-2025)
5.2.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2026-2031)
5.2.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2020-2031)
5.3 Global Lysine Specific Demethylase 1 Inhibitor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Oryzon Genomics
6.1.1 Oryzon Genomics Company Information
6.1.2 Oryzon Genomics Description and Business Overview
6.1.3 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.1.5 Oryzon Genomics Recent Developments/Updates
6.2 4SC
6.2.1 4SC Company Information
6.2.2 4SC Description and Business Overview
6.2.3 4SC Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.2.5 4SC Recent Developments/Updates
6.3 Salarius Pharmaceuticals
6.3.1 Salarius Pharmaceuticals Company Information
6.3.2 Salarius Pharmaceuticals Description and Business Overview
6.3.3 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.3.5 Salarius Pharmaceuticals Recent Developments/Updates
6.4 Celgene Corporation
6.4.1 Celgene Corporation Company Information
6.4.2 Celgene Corporation Description and Business Overview
6.4.3 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.4.5 Celgene Corporation Recent Developments/Updates
6.5 Taiho Pharmaceutical
6.5.1 Taiho Pharmaceutical Company Information
6.5.2 Taiho Pharmaceutical Description and Business Overview
6.5.3 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.5.5 Taiho Pharmaceutical Recent Developments/Updates
6.6 CSPC ZhongQi Pharmaceutical Technology
6.6.1 CSPC ZhongQi Pharmaceutical Technology Company Information
6.6.2 CSPC ZhongQi Pharmaceutical Technology Description and Business Overview
6.6.3 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.6.5 CSPC ZhongQi Pharmaceutical Technology Recent Developments/Updates
6.7 Beatica
6.7.1 Beatica Company Information
6.7.2 Beatica Description and Business Overview
6.7.3 Beatica Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.7.5 Beatica Recent Developments/Updates
6.8 Rasna Therapeutic
6.8.1 Rasna Therapeutic Company Information
6.8.2 Rasna Therapeutic Description and Business Overview
6.8.3 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio
6.8.5 Rasna Therapeutic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lysine Specific Demethylase 1 Inhibitor Industry Chain Analysis
7.2 Lysine Specific Demethylase 1 Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lysine Specific Demethylase 1 Inhibitor Production Mode & Process Analysis
7.4 Lysine Specific Demethylase 1 Inhibitor Sales and Marketing
7.4.1 Lysine Specific Demethylase 1 Inhibitor Sales Channels
7.4.2 Lysine Specific Demethylase 1 Inhibitor Distributors
7.5 Lysine Specific Demethylase 1 Inhibitor Customer Analysis
8 Lysine Specific Demethylase 1 Inhibitor Market Dynamics
8.1 Lysine Specific Demethylase 1 Inhibitor Industry Trends
8.2 Lysine Specific Demethylase 1 Inhibitor Market Drivers
8.3 Lysine Specific Demethylase 1 Inhibitor Market Challenges
8.4 Lysine Specific Demethylase 1 Inhibitor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lysine Specific Demethylase 1 Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lysine Specific Demethylase 1 Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lysine Specific Demethylase 1 Inhibitor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lysine Specific Demethylase 1 Inhibitor Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lysine Specific Demethylase 1 Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lysine Specific Demethylase 1 Inhibitor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lysine Specific Demethylase 1 Inhibitor Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lysine Specific Demethylase 1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lysine Specific Demethylase 1 Inhibitor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lysine Specific Demethylase 1 Inhibitor, Product Type & Application
 Table 12. Global Key Manufacturers of Lysine Specific Demethylase 1 Inhibitor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lysine Specific Demethylase 1 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysine Specific Demethylase 1 Inhibitor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lysine Specific Demethylase 1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2020-2025)
 Table 19. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2026-2031)
 Table 21. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2020-2025)
 Table 23. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2026-2031)
 Table 25. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lysine Specific Demethylase 1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lysine Specific Demethylase 1 Inhibitor Sales (K Units) by Type (2020-2025)
 Table 51. Global Lysine Specific Demethylase 1 Inhibitor Sales (K Units) by Type (2026-2031)
 Table 52. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2020-2025)
 Table 53. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2026-2031)
 Table 54. Global Lysine Specific Demethylase 1 Inhibitor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lysine Specific Demethylase 1 Inhibitor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2020-2025)
 Table 57. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2026-2031)
 Table 58. Global Lysine Specific Demethylase 1 Inhibitor Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Lysine Specific Demethylase 1 Inhibitor Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Lysine Specific Demethylase 1 Inhibitor Sales (K Units) by Application (2020-2025)
 Table 61. Global Lysine Specific Demethylase 1 Inhibitor Sales (K Units) by Application (2026-2031)
 Table 62. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2020-2025)
 Table 63. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2026-2031)
 Table 64. Global Lysine Specific Demethylase 1 Inhibitor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lysine Specific Demethylase 1 Inhibitor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2020-2025)
 Table 67. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2026-2031)
 Table 68. Global Lysine Specific Demethylase 1 Inhibitor Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Lysine Specific Demethylase 1 Inhibitor Price (US$/Unit) by Application (2026-2031)
 Table 70. Oryzon Genomics Company Information
 Table 71. Oryzon Genomics Description and Business Overview
 Table 72. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product
 Table 74. Oryzon Genomics Recent Developments/Updates
 Table 75. 4SC Company Information
 Table 76. 4SC Description and Business Overview
 Table 77. 4SC Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. 4SC Lysine Specific Demethylase 1 Inhibitor Product
 Table 79. 4SC Recent Developments/Updates
 Table 80. Salarius Pharmaceuticals Company Information
 Table 81. Salarius Pharmaceuticals Description and Business Overview
 Table 82. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product
 Table 84. Salarius Pharmaceuticals Recent Developments/Updates
 Table 85. Celgene Corporation Company Information
 Table 86. Celgene Corporation Description and Business Overview
 Table 87. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product
 Table 89. Celgene Corporation Recent Developments/Updates
 Table 90. Taiho Pharmaceutical Company Information
 Table 91. Taiho Pharmaceutical Description and Business Overview
 Table 92. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product
 Table 94. Taiho Pharmaceutical Recent Developments/Updates
 Table 95. CSPC ZhongQi Pharmaceutical Technology Company Information
 Table 96. CSPC ZhongQi Pharmaceutical Technology Description and Business Overview
 Table 97. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product
 Table 99. CSPC ZhongQi Pharmaceutical Technology Recent Developments/Updates
 Table 100. Beatica Company Information
 Table 101. Beatica Description and Business Overview
 Table 102. Beatica Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Beatica Lysine Specific Demethylase 1 Inhibitor Product
 Table 104. Beatica Recent Developments/Updates
 Table 105. Rasna Therapeutic Company Information
 Table 106. Rasna Therapeutic Description and Business Overview
 Table 107. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product
 Table 109. Rasna Therapeutic Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Lysine Specific Demethylase 1 Inhibitor Distributors List
 Table 113. Lysine Specific Demethylase 1 Inhibitor Customers List
 Table 114. Lysine Specific Demethylase 1 Inhibitor Market Trends
 Table 115. Lysine Specific Demethylase 1 Inhibitor Market Drivers
 Table 116. Lysine Specific Demethylase 1 Inhibitor Market Challenges
 Table 117. Lysine Specific Demethylase 1 Inhibitor Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lysine Specific Demethylase 1 Inhibitor
 Figure 2. Global Lysine Specific Demethylase 1 Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lysine Specific Demethylase 1 Inhibitor Market Share by Type: 2024 & 2031
 Figure 4. Vaccine Product Picture
 Figure 5. Monoclonal Antibody Product Picture
 Figure 6. Global Lysine Specific Demethylase 1 Inhibitor Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lysine Specific Demethylase 1 Inhibitor Market Share by Application: 2024 & 2031
 Figure 8. Breast Cancer
 Figure 9. Prostate Cancer
 Figure 10. Others
 Figure 11. Global Lysine Specific Demethylase 1 Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Lysine Specific Demethylase 1 Inhibitor Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Lysine Specific Demethylase 1 Inhibitor Sales (2020-2031) & (K Units)
 Figure 14. Global Lysine Specific Demethylase 1 Inhibitor Average Price (US$/Unit) & (2020-2031)
 Figure 15. Lysine Specific Demethylase 1 Inhibitor Report Years Considered
 Figure 16. Lysine Specific Demethylase 1 Inhibitor Sales Share by Manufacturers in 2024
 Figure 17. Global Lysine Specific Demethylase 1 Inhibitor Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Lysine Specific Demethylase 1 Inhibitor Players: Market Share by Revenue in Lysine Specific Demethylase 1 Inhibitor in 2024
 Figure 19. Lysine Specific Demethylase 1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Lysine Specific Demethylase 1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 22. North America Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 23. United States Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 26. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2020-2031)
 Figure 34. China Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Lysine Specific Demethylase 1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Lysine Specific Demethylase 1 Inhibitor by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Lysine Specific Demethylase 1 Inhibitor by Type (2020-2031)
 Figure 53. Global Lysine Specific Demethylase 1 Inhibitor Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Lysine Specific Demethylase 1 Inhibitor by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Lysine Specific Demethylase 1 Inhibitor by Application (2020-2031)
 Figure 56. Global Lysine Specific Demethylase 1 Inhibitor Price (US$/Unit) by Application (2020-2031)
 Figure 57. Lysine Specific Demethylase 1 Inhibitor Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona